Industry

Life Sciences and Health Care

Navigating complexities in the life sciences and health care industries is no easy task. Successfully competing in the space requires a partner with a holistic, collaborative approach and a global perspective. It calls for a strategy informed by asking the right questions and rooted in identifying creative solutions to...

Boston Compliance Forum

Join the Hogan Lovells Boston team along with regional and international colleagues for an informative breakfast forum in Cambridge, MA. The forum features two sessions that explore a range ...

Quick view Full view

Sponsorships and Speaking Engagements

Master Class: Medical Device Clinical Research: The Path From Concept to Approval (Part 2)

Lina Kontos is a speaker in the Master Class: Medical Device Clinical Research: The Path From Concept to Approval (Part 2) session at the Magi's Clinical Research Conference - 2018 West on...

Quick view Full view

Hogan Lovells Publications

New regulations expand CFIUS' jurisdiction and mandate filings International Trade Alert

The Department of the Treasury has released two new interim rules that (i) update existing regulations regarding the Committee on Foreign Investment in the United States (CFIUS) pursuant to ...

Quick view Full view

Hogan Lovells Publications

The Italian Competition Authority is taking a close look at the food supplement market

Co-authored and co-written by Carlotta Busani, Trainee Solicitor.

Quick view Full view

Hogan Lovells Publications

New draft guidance proposes a shift in how the FDA will evaluate certain device modifications Medical Device Alert

On September 28, 2018, the U.S. Food and Drug Administration (FDA or the Agency) issued a draft guidance document, entitled "The Special 510(k) Program," which, when finalized, will...

Quick view Full view

Hogan Lovells Publications

New anti-kickback prohibition in opioid bill creates tangled web of compliance obligations Pharmaceutical and Biotechnology Alert

On October 3, the U.S. Congress passed H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (the SUPPORT...

Quick view Full view
Loading data